U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755189) titled 'Night Driving After Trifocal Versus Monofocal IOL Implantation' on Aug. 05. Brief Summary:... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the ef... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755826) titled 'Repotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion-Positive T... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the ef... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754474) titled 'A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigat... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754682) titled 'Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Tr... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756190) titled 'Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly D... Read More